HAEMONETICS CORP Insider Trading for May 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in HAEMONETICS CORP for May 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 40.32 | 8,196 | 330,427 | 17,807 | 26 K to 17.8 K (-31.52 %) |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 36.37 | 8,196 | 298,089 | 26,003 | 17.8 K to 26 K (+46.03 %) |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 35.50 | 10,353 | 367,557 | 0 | |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | M | 34.41 | 7,118 | 244,895 | 0 | |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 40.34 | 10,353 | 417,602 | 17,807 | 28.2 K to 17.8 K (-36.76 %) |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 30.50 | 10,353 | 315,792 | 28,160 | 17.8 K to 28.2 K (+58.14 %) |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 40.31 | 7,118 | 286,917 | 17,807 | 24.9 K to 17.8 K (-28.56 %) |
May 24 2017 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Buy | M | 34.41 | 7,118 | 244,895 | 24,925 | 17.8 K to 24.9 K (+39.97 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 27.24 | 8,580 | 233,719 | 0 | |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.56 | 307 | 12,759 | 22,434 | 22.7 K to 22.4 K (-1.35 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.55 | 400 | 16,620 | 22,741 | 23.1 K to 22.7 K (-1.73 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.55 | 100 | 4,155 | 23,141 | 23.2 K to 23.1 K (-0.43 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.54 | 273 | 11,340 | 23,241 | 23.5 K to 23.2 K (-1.16 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.53 | 129 | 5,357 | 23,514 | 23.6 K to 23.5 K (-0.55 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.52 | 818 | 33,963 | 23,643 | 24.5 K to 23.6 K (-3.34 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.51 | 276 | 11,455 | 24,461 | 24.7 K to 24.5 K (-1.12 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.50 | 453 | 18,800 | 24,737 | 25.2 K to 24.7 K (-1.80 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.50 | 100 | 4,150 | 25,190 | 25.3 K to 25.2 K (-0.40 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.49 | 100 | 4,149 | 25,290 | 25.4 K to 25.3 K (-0.39 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.49 | 300 | 12,446 | 25,390 | 25.7 K to 25.4 K (-1.17 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.48 | 1,900 | 78,812 | 25,690 | 27.6 K to 25.7 K (-6.89 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.48 | 300 | 12,443 | 27,590 | 27.9 K to 27.6 K (-1.08 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.47 | 1,771 | 73,443 | 27,890 | 29.7 K to 27.9 K (-5.97 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.47 | 300 | 12,440 | 29,661 | 30 K to 29.7 K (-1.00 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.46 | 500 | 20,730 | 29,961 | 30.5 K to 30 K (-1.64 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.46 | 100 | 4,146 | 30,461 | 30.6 K to 30.5 K (-0.33 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 53 | 2,197 | 30,561 | 30.6 K to 30.6 K (-0.17 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 200 | 8,290 | 30,614 | 30.8 K to 30.6 K (-0.65 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.45 | 100 | 4,145 | 30,814 | 30.9 K to 30.8 K (-0.32 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 41.44 | 100 | 4,144 | 30,914 | 31 K to 30.9 K (-0.32 %) |
May 17 2017 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 27.24 | 8,580 | 233,719 | 31,014 | 22.4 K to 31 K (+38.25 %) |
May 15 2017 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 36.37 | 8,196 | 298,089 | 0 | |
May 15 2017 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 34.41 | 7,118 | 244,895 | 0 | |
May 15 2017 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 41.78 | 15,314 | 639,819 | 13,251 | 28.6 K to 13.3 K (-53.61 %) |
May 15 2017 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 36.37 | 8,196 | 298,089 | 31,725 | 23.5 K to 31.7 K (+34.83 %) |
May 15 2017 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 34.41 | 7,118 | 244,895 | 23,529 | 16.4 K to 23.5 K (+43.37 %) |